Incyte Corp
(MEX:INCY)
MXN
2,036
(0%)
Market Cap: 420.54 Bil
Enterprise Value: 343.15 Bil
PE Ratio: 15.36
PB Ratio: 3.82
GF Score: 85/100 Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020 / 01:30PM GMT
Release Date Price:
MXN2094.75
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Okay. Great. Welcome, everyone. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research, and we are here for a fireside chat with the management team from Incyte. I have on the line with me Hervé Hoppenot and Christiana Stamoulis, CEO and CFO of Incyte. Welcome to both of you.
HervÃ;Hoppenot
Incyte Corporation - Chairman, President & CEO
© -
Thank you. Good morning.
Christiana Stamoulis
Incyte Corporation - Executive VP & CFO
Good morning, Vikram.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Good morning. Before we go ahead and get started with the discussion, I need to read a brief disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot